NUVB DEFA14A SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

NUVB ▼ -17.61% at T+20d

NEUTRAL call ✗ call lost -17.61% · α vs SPY -22.53% · entry $5.11 → $4.21

Next anchor: T+60d in 5w

Last close $4.80 (close Jun 8) · -6.07% from $5.11 entry

Entry anchored
Apr 21, 10:53 AM ET
via Databento tick

T+1d

+0.20%

call +0.20% · α -0.82%

$5.12

settled 7w ago

T+5d

-10.76%

call -10.76% · α -11.85%

$4.56

settled 6w ago

T+20d

-17.61%

call -17.61% · α -22.53%

$4.21

settled 22d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

Nuvation Bio Inc. filed a supplemental proxy statement to correct a typographical error in the non-employee director compensation table, updating Robert Mashal, M.D.'s cash compensation from $37,500 to $47,500. The filing is routine and does not impact corporate governance, strategy, or financials.

Actionable Insight

No trading implication; this is a clerical correction. Monitor the upcoming annual meeting for any substantive governance discussions or updates on clinical development.

Key Facts

Filing is a supplement to correct a typo in director compensation disclosure.
Robert Mashal, M.D.'s cash compensation was corrected from $37,500 to $47,500 for fiscal year 2025.
Total compensation for Dr. Mashal is now $432,500, up from previously reported $422,500.
No other changes were made to the original proxy statement.
The annual shareholder meeting is scheduled for May 21, 2026.

Financial Impact

Minimal; correction increases disclosed cash compensation by $10,000 for one director in 2025.

director compensationtotal non-employee director expenses

Risk Factors

None material; this is a non-substantive correction.
Perception of weak internal controls if frequent disclosure errors occur, though isolated incident appears benign.

Market Snapshot

Exchange

NYSE

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
DEFA14A Filing (Primary)	0001140361-26-015827
Document: 0001140361-26-015827-index-headers.html	0001140361-26-015827
Document: 0001140361-26-015827-index.html	0001140361-26-015827
Document: 0001140361-26-015827.txt	0001140361-26-015827

3 reports for NUVB

T+1T+5T+20T+60

Filters

Reports for NUVB — sortable, filterable
	Type				Now
May 4, 2026 5w ago	8-K MIXED ★ 6/10	$4.83 $4.90	▲ +1.45%	▼ −3.50%	$4.80 (−0.62%)
Apr 21, 2026 7w ago	DEFA14A NEUTRAL ★ 2/10	$5.11 $4.21	▼ −17.61%	▼ −22.53%	$4.80 (−6.07%)
Apr 17, 2026 7w ago	144 NEUTRAL ★ 3/10	$5.12 $4.21	▼ −17.77%	▼ −21.98%	$4.80 (−6.25%)

US Market Status

Market Closed — Opens in 8h 32m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access